Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Ortoma

7.98 SEK

-1.48 %

Less than 1K followers

ORT B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.48 %
-30.14 %
-39.87 %
-39.87 %
-54.40 %
-11.93 %
-0.39 %
-64.77 %
+168.24 %

Ortoma operates in the medical technology sector. The company develops surgical systems for implant treatment. The technology is based on 3D models and is mainly used to plan and position implants such as hip, knee and back surgery. The products are used by orthopaedic surgeons and in various surgeries, and the business is based on research and development within the field. The company has its headquarters in Gothenburg.

Read more
Market cap
373.35M SEK
Turnover
335.96K SEK
Revenue
64.64M
EBIT %
-30.19 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13/5
2026

Interim report Q1'26

21/5
2026

General meeting '26

30/7
2026

Interim report Q2'26

All
Research
Webcasts
Press releases
ShowingAll content types
Press release3/31/2026, 9:00 AM

DNB Carnegie Access: Ortoma - Q&A + Produktdemonstration

Ortoma
Press release3/31/2026, 6:00 AM

Idag inleds teckningsperioden i Ortomas företrädesemission

Ortoma
Press release3/31/2026, 6:00 AM

The subscription period in Ortoma’s rights issue begins today

Ortoma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release3/30/2026, 7:01 AM

Ortoma erhåller regulatorisk registrering i Storbritannien för OTS™ Hip och erhåller milstolpsersättning om 0,5 MUSD

Ortoma
Regulatory press release3/27/2026, 9:08 AM

Ortoma offentliggör informationsdokument inför företrädesemissionen

Ortoma
Regulatory press release3/27/2026, 9:08 AM

Ortoma publishes information document regarding the rights issue

Ortoma
Press release3/25/2026, 10:38 AM

Ortoma bjuder in till livesänd Q&A tisdagen den 31 mars 2026

Ortoma
Regulatory press release3/24/2026, 3:59 PM

Kommuniké från extra bolagsstämma i Ortoma AB

Ortoma
Intervju med Ortomas VD under SCF:s 17:e Kapitalmarknadsdag Life Science7:22
Video3/19/2026, 7:07 AM by
Pia Maljanen

Intervju med Ortomas VD under SCF:s 17:e Kapitalmarknadsdag Life Science

Ortoma presenterade vid Stockholm Corporate Finance 17:e kapitalmarknadsdagar Life Science 2026.

Ortoma
Ortoma, Investor Day, Stockholm Corporate Finance Life Science Seminarium 2026
Webcast3/18/2026, 9:00 AM

Ortoma, Investor Day, Stockholm Corporate Finance Life Science Seminarium 2026

Ortoma
Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars
Webcast3/18/2026, 7:00 AM

Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars

Välkommen att lyssna på Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars.

Miris HoldingDevyser DiagnosticsOrtomaNextCell PharmaSaniona
Press release3/3/2026, 8:50 AM

DNB Carnegie Access: Ortoma: Withdrawing fair value

Ortoma
Regulatory press release3/3/2026, 7:00 AM

Kallelse till extra bolagsstämma i Ortoma AB

Ortoma
Regulatory press release3/3/2026, 7:00 AM

Ortoma genomför en till 100 procent garanterad företrädesemission om cirka 52 MSEK samt en riktad nyemission om 16 MSEK

Ortoma
Regulatory press release3/3/2026, 7:00 AM

Ortoma carries out a 100 per cent guaranteed rights issue of approximately SEK 52 million, and a directed new issue of shares of SEK 16 million

Ortoma
Press release2/27/2026, 7:55 AM

DNB Carnegie Access: Ortoma: A transformational year ahead for growth – Q4 review

Ortoma
Press release2/26/2026, 8:05 AM

DNB Carnegie Access: Ortoma: In line numbers – Q4 first comment

Ortoma
Regulatory press release2/26/2026, 7:00 AM

Ortoma offentliggör bokslutskommuniké för 2025

Ortoma
Press release2/4/2026, 2:28 PM

DNB Carnegie Access: Ortoma: Regulatory win in Australia for OTS Hip

Ortoma
Regulatory press release2/4/2026, 12:23 PM

Ortoma erhåller regulatorisk registrering från TGA för OTS™ Hip i Australien och erhåller milstolpsersättning om 0,5 MUSD

Ortoma
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.